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ABSTRACT The microbiomes of 83 preterm very-low-birth-weight (VLBW) infants
and clinical covariates were analyzed weekly over the course of their initial neonatal
intensive care unit (NICU) stay, with infant growth as the primary clinical outcome.
Birth weight significantly correlated with increased rate of weight gain in the first
6 weeks of life, while no significant relationship was observed between rate of
weight gain and feeding type. Microbial diversity increased with age and was signifi-
cantly correlated with weight gain and percentage of the mother’s own milk. As ex-
pected, infants who received antibiotics during their NICU stay had significantly
lower alpha diversity than those who did not. Of those in the cohort, 25 were fol-
lowed into childhood. Alpha diversity significantly increased between NICU dis-
charge and age 2 years and between age 2 years and age 4 years, but the microbial
alpha diversity of 4-year-old children was not significantly different from that of
mothers. Infants who showed improved length over the course of their NICU stay
had significantly more volatile microbial beta diversity results than and a signifi-
cantly decreased microbial maturity index compared with infants who did not; inter-
estingly, all infants who showed improved length during the NICU stay were deliv-
ered by Caesarean section. Microbial beta diversity results were significantly different
between the time of the NICU stay and all other time points (for children who were
2 or 4 years old and mothers when their children were 2 or 4 years old).
IMPORTANCE Preterm infants are at greater risk of microbial insult than full-term in-
fants, including reduced exposure to maternal vaginal and enteric microbes, higher
rates of formula feeding, invasive procedures, and administration of antibiotics and
medications that alter gastrointestinal pH. This investigation of the VLBW infant mi-
crobiome over the course of the neonatal intensive care unit (NICU) stay, and at
ages 2 and 4 years, showed that the only clinical variables associated with significant
differences in taxon abundance were weight gain during NICU stay (Klebsiella and
Staphylococcus) and antibiotic administration (Streptococcus and Bifidobacterium). At
2 and 4 years of age, the microbiota of these VLBW infants became similar to the
mothers’ microbiota. The number of microbial taxa shared between the infant or
toddler and the mother varied, with least the overlap between infants and mothers.
Overall, there was a significant association between the diversity and structure of
the microbial community and infant weight and length gain in an at-risk childhood
population.
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Humans have canonically been considered sterile in utero, with the majority ofmicrobial colonization occurring during and immediately following birth. This early
microbial exposure begins a dynamic process, activating the immature immune system
and leading to the selection of particular microbes. At birth, gut-associated lymphoid
tissue is “uneducated” and the innate immune response to the presence of bacteria is
crucial for the transition from fetal to postnatal life (1, 2). Recent evidence suggests that
there are time-dependent windows of development that are contingent upon microbial
signals to trigger maturation of mucosal immunity. For example, the microbiome at
2 months of age has been shown to be predictive of a child’s interleukin expression
levels at 2 years of age (3). Indeed, children with altered microbiome development
show an increased incidence of immune-mediated disorders in adulthood (4–7). This
implies that perturbations or abnormal assembly during this early life interval may have
lifelong health consequences.
The ecological succession of the human microbiome in healthy, full-term infants has
been well documented and shows a patterned progression from birth to an “adult-like”
state around 2.5 years postpartum (8, 9). Initial colonizers of the infant gut are typically
facultative anaerobes, shifting to obligate anaerobes within days or weeks (10) as the
maturing colonocytes start to scrub oxygen from the intestinal lumen (11). In preterm
infants, the microbiome undergoes a similar pattern of development, but does so after
a significant delay (12). The preterm infant microbiome is characterized by low diversity
and low stability, as well as by an abundance of opportunistic pathogens (13). Micro-
biota development in premature infants appear to be associated with gestational age
but is also shaped by maternal environment and lifestyle and by the unique environ-
ment and clinical practices in the neonatal intensive care unit (NICU) (14–17). Preterm
infants are exposed to high levels of antibiotics and low levels of maternally derived
microbes, leaving them particularly susceptible to colonization from an environmental
source, such as the NICU built environment, which may harbor antibiotic resistance
genes (13, 18). Furthermore, a recent study of late-preterm infants, who are likely to
receive postnatal care similar to that received by full-term infants, determined that
late-preterm birth independently affected gut microbiome development during the
first 6 months of life (19).
The goals of this study were to analyze the gut microbiome during the first 6 weeks
after birth for very-low-birth-weight (VLBW) infants and to determine the associations
between the variance in microbial profile and infant health outcomes. Subsequently, 25
of the original 83 children were reexamined at ages 2 and 4, and the stool microbial
profile was assessed with respect to health, development, and growth (weight and
length) outcomes. We hypothesized that microbial community structure present in the
first 6 weeks of the NICU stay is statistically associated with mode of delivery, gesta-
tional age, weight and length gain, type of feeding, human milk cytokines, fecal
calprotectin, and adverse prenatal events and that the microbial community structure
of the infant gut microbiome can be used to predict the microbial community structure
in the same child at 2 and 4 years of age.
RESULTS
Overview of the preterm infant cohort. Preterm infant clinical variables (see
Table S1 in the supplemental material) were determined for a population cohort of 83
preterm infants delivered at Tampa General Hospital between May 2012 and Dec 2013.
Each child was sampled for fecal matter approximately weekly for up to 6 weeks during
the NICU stay and was then followed up at 2 years old and 4 years old. Of the 83
subjects in the original sample, only about 57 were locatable at 2 years of age, and 25
were recruited from that group for follow-up, which significantly impacted the statis-
tical power of our analyses to develop a predictive model of the microbial community
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structure between the NICU stay and childhood. The longitudinal analysis comprised
425 fecal samples, which were processed for 16S rRNA amplicon sequencing to
characterize the microbiome.
Relevant available age metrics included gestational age at birth, chronological age,
and postmenstrual age. Infants in our cohort had a wide range of gestational ages at
birth (24 to 37 weeks). Therefore, chronological age was not employed as the inde-
pendent variable; instead, we used postmenstrual age (chronological age plus gesta-
tional age; also known as corrected gestational age) for all subsequent analyses. A total
of 91.6% of the infants started antibiotics on first day of life (regardless of gestational
age). The mean postmenstrual age for starting antibiotics was 28.2  2.5 (standard
deviation [SD]) weeks. Most infants were on antibiotics for 3 to 4 days at a time, with
a median course of antibiotics lasting 3.5 days. Only 7 infants did not receive any
antibiotics. The mean total number of days on antibiotics was 11.88  18.8 (range, 0 to
114 days).
In total, 6,383,544 16S rRNA amplicon reads were generated across all 425 samples,
with a range of 1,000 to 40,483 reads (median, 13,092; mean, 15,020.1). Sequence
depth was rarified to 1,275 reads per sample, resulting in 415 samples used in
subsequent analysis. Reads were classified into exact sequence variants (ESVs) using
DADA2, creating a total of 2213 ESVs, with a range of 1 to 1,844,477 reads per sample
(median, 48; mean, 2,884.5). All ESVs were annotated to known microbial taxa.
Infant growth as a clinical outcome. Our analyses were statistically underpowered
for each morbidity category (only 5 infants with chronic lung disease [CLD], 3 with
necrotizing enterocolitis [NEC], 10 with blood culture-positive sepsis, and 9 with any
stage of intraventricular hemorrhage [IVHn]); therefore, we focused on growth (in-
creased weight and length) as a primary clinical outcome during the NICU stay. We
tested the independence of the measured growth variables (Materials and Methods).
Birth weight (in grams) was significantly correlated with growth rate over the first
6 weeks of life (grams/week) (see Fig. S1 in the supplemental material). Overall, there
was a weak but significant association between higher initial birth weight and faster
initial weight gain (R2 0.146, P value  0.001703); however, this relationship was not
significant for birth weight and weight gain between 6 weeks and discharge
(P 0.8141). No significant relationships were observed between weight at discharge
and weight gain with feeding (total volume of milk received and ratio of mother’s
breast milk volume to total enteral feeding volume received; P 0.2).
Microbial diversity increased with age and was statistically associated with
clinical variables. The relationship between weight and length gain outcomes and
microbial alpha diversity over the course of the NICU stay was determined. Shannon
index values increased significantly with increasing postmenstrual age (multiple R2,
0.09221; P  1.28e08) (Fig. 1, left panel). Adjusting for postmenstrual age during the
NICU stay, the alpha diversity also showed weak but significant correlations with the
overall rate of weight gain (multiple R2, 0.144; P 0.00208) (Fig. 1, middle panel) and
the total percentage of the mother’s own milk (MOM; multiple R2, 0.1097; P 0.024918)
(Fig. 1, right panel), but no statistically significant associations were observed with the
following other clinical variables: mode of delivery, length of hospitalization in the
NICU, time to full enteral feeding, days on antibiotics, infant weight at birth or
discharge, days on oxygen, APGAR (appearance, pulse, grimace, activity, and respira-
tion) scores at 1 or 5 min postbirth, duration of breast-feeding, or maternal age. We
found no significant associations with microbial alpha diversity and common comor-
bidities, although our analyses lacked statistical power within the cohort for each
morbidity. As expected, infants who received antibiotics during the NICU stay had
significantly lower alpha diversity than those who did not receive antibiotics (t test,
false-discovery-rate [FDR] corrected, P 0.009). Values for Shannon alpha diversity
difference per infant between the first NICU stool sample and the last stool sample
ranged from 3.3520 to 3.1720, with a median of 0.8259. There were no significant
differences with respect to delta Shannon alpha diversity between children who
Preterm Infant Growth and Microbiome Stability
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showed improved length and those who did not or by mode of delivery (P 0.3; t test,
FDR correction).
A significant increase in Shannon index values was also observed for each child in
comparisons between their last time point of NICU stay and 2 and 4 years of age (P 
0.01; t test); the Shannon index values were also significantly different in comparisons
FIG 1 Correlation of alpha diversity with (left panel) postmenstrual age (Shannon: multiple R2 value, 0.1508; P value, 1.507e06), (middle
panel) total growth rate (in grams/week), and (right panel) ratio of the mother’s own milk volume to total milk volume.
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of 2 and 4 years of age. While the alpha diversity during the NICU stay and at 2 years
of age was significantly lower than the alpha diversity of the mother’s stool-associated
microbiota (P  0.01; t test), the alpha diversity at 4 years of age was not significantly
different from that of the mother, suggesting that the diversity normalizes to that of an
adult by 4 years of age.
Microbial beta diversity, maturity, and microbial stability. The distribution of
between-sample unweighted UniFrac distances was calculated pairwise to determine
the volatility of microbial community structure over time during the NICU stay. This was
then associated with the clinical variables, including both categorical variables (delivery
method, sex, gestational age, weight for gestational age, improved length, multiples,
weight gain rate, ratio of volume of breastmilk to total volume of milk received, length
of stay in NICU) and binary variables (antibiotic treatment, sepsis, NEC, CLD, transfu-
sions, feeding intolerance). Beta diversity volatility was significantly correlated with
improved length only during the NICU stay, with results indicating that infants who
showed improved length had significantly more intersample variability in beta diversity
and hence had greater microbial volatility over the course of their NICU stay
(P 0.02805; FDR corrected). This suggests that infants with a less-volatile microbiota
over time may have reduced catch-up growth (length) during the NICU stay. While the
mode of delivery alone did not correlate with volatility, all the infants with improved
length (n 6) had been delivered by Caesarean section.
We ran a “maturity” analysis (Materials and Methods), which uses a regression model
to predict postmenstrual age as a function of the composition of the microbiota.
Therefore, if a sample had a microbiota which fell outside the confidence interval based
on the average microbiota composition for infants of each postmenstrual age, it was
considered immature. We correlated the maturity index with improved length during
their NICU stay (Fig. 2). Those infants who did have improved length during their NICU
stay had a significantly reduced level of predicted microbial maturity compared to
infants whose length did not significantly increase (P 0.0018). As maturity is inversely
correlated with beta diversity volatility, this result agrees with the results of the beta
diversity volatility analysis described above.
We also examined the beta diversity distribution (unweighted UniFrac) to determine
the microbial community structure variance between the final NICU time point, age 2
FIG 2 Maturity analysis data showing actual versus predicted gestational age at birth for infants showing
or not showing improved length.
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years and age 4 years, and maternal samples. The maternal microbiota and those of the
2-year-old and 4-year-old children also clustered together and were significantly dif-
ferent from those seen with the samples collected at the end of the NICU stay (Fig. 3;
principal-coordinate analysis [PCoA], P 0.05 after FDR).
Microorganisms associated with clinical outcomes and age. The stool samples
collected during the NICU stay maintained a predominance of Gammaproteobacteria,
specifically, Enterobacteriaceae, members of which are often associated with lipopoly-
saccharide (LPS)-mediated inflammation. The most abundant exact sequence variant
(ESV) in infants during the NICU stay was closely related to the genus Klebsiella, which
belongs to the Enterobacteriaceae. Analysis of composition of microbiomes (ANCOM)
was applied against all categorical and binary clinical variables to determine which
bacteria were significantly differentiated in relative abundance. Only two clinical vari-
ables showed bacteria that were significantly differentially abundant. Infant weight
gain from birth to discharge was significantly negatively correlated with the relative
abundance of two ESVs, one associated with Klebsiella and the other related to
Staphylococcus (P 0.01). Additionally, antibiotic administration was associated with
significant enrichment in Proteus levels and a significant proportional decrease in the
levels of Streptococcus and Bifidobacterium compared to infants who did not receive
antibiotics (P 0.01). The predominance of Proteobacteria was greater in infants with
lower beta diversity volatility than in those with higher volatility.
The random forest classifier was used to determine whether the microbiota was
predictive of categorical clinical variables (clinical factors that could be grouped into
discrete components), with results which suggested that only the use of antibiotics
(presence/absence) could be accurately predicted, with a baseline-to-random ratio of
2 (2.26) suggesting a marginal relationship. The random forest features identified as
having the most predictive value for the presence or absence of antibiotics were ESVs
corresponding to Enterobacteriaceae, Citrobacter, Escherichia, and Peptostreptococ-
caceae. For continuous clinical variables, we also ran the random forest regressor model
(1,000 estimators, bootstrapping, mean square error [MSE]), which identified only the
duration of antibiotic administration as significantly predictable (R2 of 0.16259;
P 0.000651). The top most important features for the regressor-model accuracy were
ESVs corresponding to Veillonella, Enterobacteriaceae, Proteus, and Escherichia (impor-
tance scores of 0.15 to 0.05).
While the infant samples at 6 weeks of life had a significantly greater abundance of
ESVs related to Enterococcus and Staphylococcus (Kruskal-Wallace; Bonferroni-corrected
P 0.0001), samples from toddler at both 2 and 4 years old maintained ESVs associated
with Clostridiales and Bacteroidales that were not detected in the infant samples for the
respective individuals. However, the infants as a group shared 26 ESVs in total with
2-year-old toddlers as a group, 26 ESVs in common with 4-year-old toddlers, and 18
ESVs in common with the mothers as group (Fig. 4). Interestingly, the 2-year-old
toddlers shared 155 ESVs with their mothers, while the 4-year-old children shared 210
ESVs with their mothers. This suggests that the number of ESVs shared with the mother
increases with increasing age, likely due to the changing gut environment and an
increase in food similarity. In total, only 14 ESVs were shared between infants, 2-year-
old and 4-year-old children, and mothers; those comprise the core ESVs. The ESVs
included genera such as Ruminococcus, Oscillospira, Bacteroides, Streptococcus, Bifido-
bacterium, Escherichia, Eggerthella, and Dorea and families such as Lachnospiraceae,
Peptostreptococcaceae, and Rikenellaceae (Table S2). Interestingly, one of the core ESVs
found in all age groups was related to Haemophilus parainfluenzae, which is a potential
pathogen. Overall, the H. parainfluenzae ESV was found in 10% of the samples, from
29% (24) of the participants. Some infants maintained the H. parainfluenzae ESV over
multiple NICU time points, but it was not found in the corresponding 2-year-old and
4-year-old samples for those infants. However, it was found in 3 children at both 2 years
of age and 4 years of age and also in their mothers. As mothers’ stool samples were
collected at the same time as the stool samples collected from the 4-year-olds, it is
Yee et al.
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FIG 3 Unweighted Unifrac Beta diversity PCoA of infant samples (i.e., those from the last NICU time point) and samples from 2-year-old children, 4-year-old
children, and mothers.
Preterm Infant Growth and Microbiome Stability
January/February 2019 Volume 4 Issue 1 e00229-18 msystems.asm.org 7
possible that this H. parainfluenzae ESV represented endemicity in these 3 families
during that time.
DISCUSSION
Preterm infants are particularly vulnerable to perturbations in gut microbiome
development due to their abnormal delivery and prolonged NICU stay, which is
associated with many insults. Our study results complement prior observations show-
ing that the preterm infant microbiome is characterized by an abundance of Proteo-
bacteria (20, 21). Bacterial alpha diversity was significantly positively correlated with
postmenstrual age, and, adjusted for postmenstrual age during the NICU stay, the alpha
diversity also showed weak but significant correlations with overall rate of weight gain
and total volume of the mother’s own milk.
While we did not identify significant differences between infants’ microbial beta
diversity data by mode of delivery or feeding type, we did, as expected, find an effect
of antibiotic administration, which correlated with a significant enrichment of Proteus.
Proteus, a gammaproteobacterial genus, can be an opportunistic pathogen in humans
and is frequently found in hospital settings (22, 23). It has been associated with high
rates of biofilm formation and antibiotic resistance, which may explain its increased
abundance following antibiotic perturbation in our study. Furthermore, postmenstrual
age (gestational age plus chronological age, also known as corrected gestational age)
accounted for the majority of variance in beta diversity over time. Infant weight gain
during the NICU stay was negatively correlated with the relative abundances of
FIG 4 UpSet plot showing ESVs shared between infant samples and samples from 2-year-old children, 4-year-old children, and mothers. The numbers of unique
ESVs shared between groups or intersections of groups are plotted as vertical bars. The 14 “core” ESVs shared between all four sample groups are indicated
in blue.
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Klebsiella and Staphylococcus. As both of these taxa are associated with known patho-
gens, it is possible that their enrichment may be indicative of dysbiosis, which in turn
appears to be associated with reduced infant weight and length gain, although to the
best of our knowledge this specific association has not been demonstrated previously.
However, a previous study demonstrated a significant association between bacterial
alpha diversity and body weight and gestational age, which were also associated with
an increase in the level of staphylococci (24).
We also demonstrated that the z-score corresponding to catch-up growth in length
(improved length) was correlated with increased beta diversity volatility (between-
sample beta diversity distance) and decreased maturity (predictive power of regressor
modeling) during the NICU stay. Catch-up growth is an important consideration for
preterm infants: VLBW infants are vulnerable to extrauterine growth restriction, and
caloric and protein deficits result in lower growth velocity and are associated with
major neonatal morbidities, including chronic lung disease and retinopathy of prema-
turity (25). Clinically, it is believed that early catch-up growth (at 2 years, and
especially in the first 24 weeks of life) is beneficial to preterm-delivered child health
outcomes (26, 27). That microbial beta diversity was more volatile for children who
demonstrated greater catch-up growth could be related to the overall microbial profile
for this community. Infants with lower volatility had significantly greater predominance
of Proteobacteria; i.e., they had greater week-to-week stability due to the dominance of
a group of potential pathogens (e.g., Klebsiella). Infants with more volatility had reduced
prevalence of these organisms and as such may have had reduced dysbiosis and
improved growth. This report is among the first to document a relationship between
microbiome and VLBW infant growth. Previous work found that preterm infants with
prolonged microbial transitions had smaller changes in weight-for-age z-scores across
time (14). However, little is known about the relationship between preterm/VLBW
length gain and microbiome development. Poor length gain, as an indicator of long-
term nutritional stress, indicates that microbiome development can have a long-term
effect on infant phenotype. Researchers have noted that the preterm microbiome has
developmental signatures similar to those seen with undernourished term infants (28),
suggesting that the therapeutic approaches may be similar for the two groups. More
research is needed to establish the relationship between VLBW length and weight gain
and microbiome development.
Due to the limited size of this cohort, it is not possible to determine if this trend is
absolutely significant, but the data suggest that further studies using larger cohorts
would be useful, as would studies involving the humanization of murine models to
demonstrate reduced growth as a transferable phenotype. Those infants who demon-
strated reduced microbial maturity also showed improved catch-up growth, likely as a
result of the choice of population against which these infants were compared. Our
maturity analysis is based on the average maturity data determined for a population of
VLBW infants who were essentially quite sick, as infants in that category who showed
improved catch-up growth would be statistical outliers against this group. Having a
healthy control population might provide a more accurate interpretation of the stan-
dard maturity analysis data.
In our cohort, we followed the same children to ages 2 and 4 years. Our analyses had
insufficient statistical power to identify clinical outcomes that correlated with micro-
biome composition, but we did find that the these VLBW infants did develop a
microbiome comparable to that of their adult mothers by ages 2 to 4 years. As
previously demonstrated, the microbiome of children undergoes patterned progression
to become more similar to the maternal microbiome as the children increase in age,
with an adult-like microbiome established by 4 years (12). In our cohort of VLBW
preterm infants, we also observed shifts in the microbiome and increasing similarity to
the maternal microbiome with increasing age. Importantly, many of the ESVs found in
infants were also found in 2- and 4-year-olds, as well as in the mothers, suggesting
conservation of microbial composition between generations, ages, and environments.
And yet the level of ESV overlap in infants and mothers was significantly lower than that
Preterm Infant Growth and Microbiome Stability
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in mothers and 4-year-old children, suggesting a gradual shift of the microbial com-
munity, likely as a result of changes in the ecological drivers that shape the niche
structure of the developing gastrointestinal tract. For example, as the gut matures and
the immune system becomes educated and the child starts to eat food more similar to
that eaten by the adult mother, there is a selective ecological pressure toward a more
similar microbial structure (11, 29–33).
We have demonstrated a significant association between the diversity and structure
of the microbial community and infant growth in a significantly at-risk childhood
population. While the population had inherent variability, which limits the potential to
identify associations between the microbiota and clinical outcomes, compelling corre-
lations between microbial structure, volatility, maturity, and composition and infant
weight and length increases were determined that suggest potential biomarkers of
dysbiosis in this at-risk population.
MATERIALS and METHODS
The study was approved by both the hospital and the university Institutional Review Board, and
parents gave informed consent for the study in the NICU and agreed to be followed up at a later time
for further research.
Patient demographics and clinical information. A total of 83 preterm, very-low-birth-weight
(VLBW) and extremely low-birth-weight (ELBW) infants (gestational age  28.44 2.39 weeks, birth
weight  1,086.71 218.49 g) were enrolled as soon as possible after admission to the neonatal
intensive care unit (NICU) at Tampa General Hospital, an academic level III center with a single-patient-
room floor plan, during the period May 2012 to December 2013. Mothers who were drug abusers or HIV
positive were excluded, as were infants who had major congenital anomalies or who were moribund.
Maternal and neonatal clinical information was obtained from electronic medical records and an
investigator-developed demographic form. Long-term morbidity data were extracted from the Vermont
Oxford Network database. Data were collected for a total of 6 weeks after entry into the study unless
participants were discharged or transferred earlier. Exact volumes of the mother’s own milk (MOM),
formula, fortifier, and donor milk (DM) were collected from the electronic medical record.
Stool sampling, DNA extraction, and amplicon sequencing. Stool samples were scooped asep-
tically from a diaper at approximately the end of each week (with some variation), stored in a sterile tube,
brought to the laboratory, and frozen at 80°C until processing. DNA was extracted using a MoBio
PowerFecal DNA kit (Qiagen, Carlsbad, CA) with modifications based on the Earth Microbiome Project
protocols (www.earthmicrobiome.org). The V4 region of 16S rRNA gene was amplified using PCR with
modified 515F and 806R primers, followed by amplicon sequencing using a MiSeq platform (Illumina, San
Diego, CA) based on existing protocols to generate 100,000 250-bp paired-end reads per sample (34).
Raw sequence reads are available through the Sequence Read Archive (SRA) (see below).
Sequencing data processing. The V4 region 16S rRNA gene amplicon data were analyzed using the
DADA2 plugin (35) in QIIME2 (36). Data from 6 separate sequencing runs were imported into QIIME2-
2018.2 and demultiplexed with demux emp-paired. The DADA2 plugin was used for quality control,
including filtering phiX reads and chimeric sequences. Trimming was performed to trunclen 140 and trim
20, and the resulting feature tables were merged. Taxonomy was assigned against the Greengenes v13.8
database.
Statistics and machine learning. We calculated the correlation between the relative abundances of
the sequence variants and NICU health outcomes by regression analysis in R. We employed UniFrac
distances to examine microbiome structure comparisons between samples to test differences between
groups using multivariate statistical methods such as principal-coordinate analysis (PCoA) and permu-
tational multivariate analysis of variance (PERMANOVA). We performed two-sample t tests with FDR
correction to examine differences between binary variables. Volatility analysis was performed by com-
paring unweighted UniFrac distances for exact sequence variants (ESVs) between subgroups. To identify
the predictive value of subgroups for microbiome community composition, we applied random forest
machine learning (after rarefication to 5,000 sequences/sample [1,000 trees]) and Analysis of Composi-
tion of Microbiomes (ANCOM) (37). For continuous clinical variables, we ran the random forest regressor
model (1,000 estimators, bootstrapping, mean square error [MSE]). Maturity analysis was applied using
the sample classifier plugin in QIIME2 (38). UpSet plots were generated using the R package (39).
Infant growth metrics. Infant weight and length were measured at birth and weekly until discharge.
Raw weight and length measurements were standardized against the 2013 revision of the Fenton
preterm growth chart using the actual-age calculator tool (40). This process converts the raw measure-
ment to z-scores based on means and standard deviations of data representing the reference population
at each age. This resulted in a weight-for-age and length-for-age z-score at each time point. Standard-
izing weights and lengths in this manner allows infants of different sexes and gestational ages to be
compared as representatives of one population. In addition, because the Fenton method is intended to
represent the ideal growth of preterm infants, it can be used to detect changes in growth status as they
age. Therefore, a change in z-score over time can be a useful tool to detect growth faltering (a z-score
that becomes smaller) and catch-up growth (a z-score that becomes larger).
Growth (weight gain and length-for-age z-score) over the NICU stay was assessed with the following
measurements: (i) total average growth rate (difference between birth weight and discharge weight
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divided by length of stay), growth rate between birth and 6 weeks of life (difference between birth
weight and weight at 6 weeks divided by weight at 6 weeks), and growth rate between 6 weeks of life
and discharge (difference between weight at 6 weeks and discharge weight divided by length of stay
minus weight at 6 weeks); (ii) weight for gestational age (categorical variables: small for gestational age,
average for gestational age, or large for gestational age), and (iii) improved length (binary variable
corresponding to whether or not the infant had greater-than-expected length-for-age z-scores during
the NICU stay). Complete growth metadata were available for only 78 of the total of 83 infants.
Data availability. The study was registered in dbGaP under accession number phs001578.v1.p1.
Deidentified metadata and raw forward and reverse sequence reads were associated with each sample
via SRA. Raw sequence reads are available through the Sequence Read Archive under accession number
SRP171050 (BioProject number PRJNA449987).
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Supplemental material for this article may be found at https://doi.org/10.1128/
mSystems.00229-18.
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